Zumutor Biologics: Funding, Investors & Team (Sep 2026)
Zumutor is a biotechnology company focused on developing immuno-oncology therapies that harness the body's innate immune system to treat cancer. The company specializes in the discovery and development of therapeutic antibodies designed to activate natural killer (NK) cells and modulate the tumor microenvironment. Its proprietary INABLR® antibody discovery platform supports the identification and optimization of novel antibody candidates for oncology applications. Zumutor is advancing a pipeline of monoclonal antibody therapies, including ZM008, which targets immune checkpoint pathways involved in tumor immune evasion and is being evaluated for the treatment of solid tumors. In addition to its internal drug development programs, the company provides antibody discovery and development capabilities that support the creation of next-generation biologic therapies.
Zumutor Biologics has raised $7.3M across 1 funding round on record, the most recent a Series B of $7.3M announced in Jun 2026.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Zumutor Biologics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Zumutor Biologics Funding Rounds
Zumutor Biologics Founders and Leadership Team
No contact details are on record for this team yet.
Zumutor Biologics Funding Compared to Other Biotechnology Startups
Zumutor Biologics' latest round of $7.3M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Zumutor Biologics in Biotechnology and Woburn
Companies Similar to Zumutor Biologics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Zumutor Biologics Funding FAQs
What does Zumutor Biologics do?
Zumutor is a biotechnology company focused on developing immuno-oncology therapies that harness the body's innate immune system to treat cancer. The company specializes in the discovery and development of therapeutic antibodies designed to activate natural killer (NK) cells and modulate the tumor microenvironment. Its proprietary INABLR® antibody discovery platform supports the identification and optimization of novel antibody candidates for oncology applications. Zumutor is advancing a pipeline of monoclonal antibody therapies, including ZM008, which targets immune checkpoint pathways involved in tumor immune evasion and is being evaluated for the treatment of solid tumors. In addition to its internal drug development programs, the company provides antibody discovery and development capabilities that support the creation of next-generation biologic therapies.
How much funding has Zumutor Biologics raised?
Zumutor Biologics has raised $7.3M across 1 round on record. The most recent is a Series B of $7.3M announced in Jun 2026.
When did Zumutor Biologics last raise funding?
Zumutor Biologics' most recent funding round on record is a Series B of $7.3M, announced in Jun 2026.
Who founded Zumutor Biologics?
FundedIQ lists Kavitha Iyer (Founder) at Zumutor Biologics.
Where is Zumutor Biologics headquartered?
Zumutor Biologics is based in Woburn, Massachusetts, United States.
How many employees does Zumutor Biologics have?
Zumutor Biologics is in the 11-50 employee band.
How does Zumutor Biologics' funding compare to other Biotechnology startups?
Zumutor Biologics' latest round of $7.3M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Zumutor Biologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zumutor Biologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.